Portal de Periódicos da CAPES

Erratum: A quantitative approach to benefit‐risk assessment of medicines — part 2: the practical application of a new model

2007; Wiley; Volume: 16; Issue: 8 Linguagem: Inglês

10.1002/pds.1460

1099-1557

Filip Mussen, Sam Salek, Stuart Walker,

Pharmacovigilance and Adverse Drug Reactions

Abstract Pharmacoepidemiology and Drug Safety 2007; 16 : S16—S41; DOI: 10.1002/pds.1434 It has come to the attention of the authors that this published article contained an error. The author Lawrence Phillips was mistakenly omitted from the original article. The full list of authors and affiliations can be seen below. Filip Mussen 1,2 , Sam Salek 2 , Stuart Walker 3 and Lawrence Phillips 4 1 Regulatory Affairs Europe, Merck Sharp & Dohme (Europe), Inc., 5 Lynx Binnenhof, Brussels, B‐1200, Belgium 2 Centre for Socioeconomic Research, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff CF10 3XF, UK 3 CMR International, Novellus Court, 61 South Street, Epsom, Surrey, KT18 7PX, UK 4 Visiting Professor of Decision Sciences, Department of Management, Operational Research Group, London School of Economics, UK The authors wish to apologise for any inconvenience caused.